Testing effectiveness (Phase 2)UnknownNCT05479032What this trial is testingAmantadine for Neuroenhancement in Acute Patients StudyWho this might be right forDisorder of Consciousness University Hospital Tuebingen 50
Early research (Phase 1)Study completedNCT04461353What this trial is testingEvaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult VolunteersWho this might be right forSevere Acute Respiratory Syndrome Coronavirus 2 Pulmoquine Therapeutics, Inc 12
Large-scale testing (Phase 3)UnknownNCT04446130What this trial is testingStudy of Decitabine Combined With HAAG Regimen in Newly Diagnosed ETP-ALL/LBL, T/M-MPAL and ALL/LBL With Myeloid or Stem Cell Markers PatientsWho this might be right forInduction ChemotherapyAcute T-Lymphocytic LeukemiaT-cell Lymphoblastic Lymphoma Leukemia+1 more The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT00313300What this trial is testingSafety Study of Apixaban in Recent Acute Coronary SyndromeWho this might be right forAcute Coronary Syndrome (ACS) Bristol-Myers Squibb 1,741
Large-scale testing (Phase 3)Looking for participantsNCT06819592What this trial is testingPRophylaxis Against Early VENTilator-associated Infections in Acute Brain InjuryWho this might be right forAll-cause MortalityQuality of LifeDisability, Intellectual+4 more The George Institute 3,300
Testing effectiveness (Phase 2)Active Not RecruitingNCT00392353What this trial is testingVorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaWho this might be right forAcute Erythroid LeukemiaAcute Megakaryoblastic LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome+6 more National Cancer Institute (NCI) 135
Early research (Phase 1)Active Not RecruitingNCT02159495What this trial is testingGenetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell NeoplasmWho this might be right forAdult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT04969601What this trial is testingAnti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsWho this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)Looking for participantsNCT06488300What this trial is testingAssessing Antiviral Treatments in Early Symptomatic RSVWho this might be right forRespiratory Syncytial VirusRespiratory Syncytial Virus, Human University of Oxford 1,000
Very early researchEnded earlyNCT01694381What this trial is testingResearch Into the Effect of a Clot-dissolving Agent and Its InhibitorWho this might be right forAcute Ischemic Stroke TSI, LLC 8
Testing effectiveness (Phase 2)Study completedNCT05659992What this trial is testingClinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01251575What this trial is testingSirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell Lymphoma+21 more Fred Hutchinson Cancer Center 77
Early research (Phase 1)Ended earlyNCT00376519What this trial is testingUmbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+3 more Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT02484430What this trial is testingSapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative+3 more National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Looking for participantsNCT05691244What this trial is testingAssess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokeWho this might be right forAcute Ischemic StrokeCerebral Stroke Pharmazz, Inc. 514
Early research (Phase 1)Looking for participantsNCT05834244What this trial is testingA Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)Who this might be right forAcute Myeloid Leukemia M.D. Anderson Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT01020734What this trial is testingDonor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in RemissionWho this might be right forLeukemia Asan Medical Center 263
Large-scale testing (Phase 3)UnknownNCT04475224What this trial is testingPhase 3 Study of KP-100IT in Subjects With Acute Spinal Cord InjuryWho this might be right forAcute Spinal Cord Injury Kringle Pharma, Inc. 25
Early research (Phase 1)Study completedNCT03915379What this trial is testingJNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Who this might be right forLeukemia, Myeloid, AcuteMyelodysplastic Syndromes Janssen Research & Development, LLC 68
Early research (Phase 1)Looking for participantsNCT04024761What this trial is testingTrial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more Dana-Farber Cancer Institute 50